<?xml encoding="utf-8" ?> A nationwide initiative to accelerate personalized cancer vaccine development is drawing fresh ...

Moderna stock popped 9% on Friday after the New York Times reported new details about an effort to speed up cancer vaccine ...

Moderna stock popped 9% on Friday after the New York Times reported new details about an effort to speed up cancer vaccine development. Investors saw the mRNA biotech company, in particular, as a ...

New details have emerged about an initiative that starts in December to fast-track the vaccines, similar to the successful ...

Vaccine and biotechnology names are leading a sharp sector rally, and a small protein-vaccine developer is posting the ...

Moderna stock gains on reports of an initiative to accelerate cancer vaccine development. Here’s why caution is warranted in ...

Saudi Arabia's flagship biotech gathering is no longer a regional talking shop. The Riyadh Global Medical Biotechnology Summit closed its ...

Sen. Curtis tells global health leaders that international cooperation remains essential, but warned that America’s growing ...

Swedish biotech will present the Phase II ADVANCE trial design for vaccine candidate ALZ-101 at Alzheimer’s disease ...

The market dynamics for Epstein-Barr virus (EBV) are evolving, driven by the high prevalence of infection worldwide, the growing recognition of EBV-associated malignancies and other complications, and ...

Australia’s national science agency has teamed up with American biotechnology giant Moderna to help boost the nation’s preparedness for ...

Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, PhD, former Research & Early Translational ...